America First Investment Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

America First Investment Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-62,947	Closed	-$107K	–	94
2018 Q3	$107K	Hold	62,947	–	–	0.03%	49
2018 Q2	$110K	Hold	62,947	–	–	0.04%	48
2018 Q1	$115K	Hold	62,947	–	–	0.04%	47
2017 Q4	$140K	Hold	62,947	–	–	0.05%	47
2017 Q3	$183K	Hold	62,947	–	–	0.07%	42
2017 Q2	$280K	Hold	62,947	–	–	0.1%	38
2017 Q1	$293K	Hold	62,947	–	–	0.11%	40
2016 Q4	$383K	Hold	62,947	–	–	0.16%	37
2016 Q3	$347K	Hold	62,947	–	–	0.15%	39
2016 Q2	$239K	Hold	62,947	–	–	0.1%	42
2016 Q1	$174K	Buy	+62,947	New	+$228K	0.08%	45
2014 Q4	–	Sell	-10,829	Closed	-$30K	–	164
2014 Q3	$30K	Hold	10,829	–	–	0.01%	87
2014 Q2	$44K	Buy	+10,829	New	+$46K	0.02%	83

Other funds holding SGYP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OCM

Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

America First Investment Advisors's SGYP Position: Q4 2018 in Review

America First Investment Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 62,947 shares — an estimated $107K sold.

America First Investment Advisors first reported a position in SGYP in Q2 2014 and held it in 13 quarters. The position peaked at $383K in Q4 2016. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

America First Investment Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
America First Investment Advisors sold 62,947 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $107K.
America First Investment Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2014 and held it in 13 quarters.
America First Investment Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $383K in Q4 2016.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on America First Investment Advisors's 13F filing for Q4 2018, filed 16 Jan 2019.